Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810K Buy
2,237
+3
+0.1% +$1.03K 0.15% 91
2026
Q1
$786K Sell
2,234
-333
-13% -$119K 0.16% 86
2025
Q4
$840K Sell
2,567
-1,570
-38% -$498K 0.16% 88
2025
Q3
$1.17M Buy
4,137
+26
+0.6% +$7.54K 0.23% 77
2025
Q2
$1.15M Buy
4,111
+75
+2% +$21.2K 0.24% 76
2025
Q1
$1.26M Sell
4,036
-626
-13% -$185K 0.29% 71
2024
Q4
$1.22M Buy
4,662
+158
+4% +$46.9K 0.26% 75
2024
Q3
$1.45M Sell
4,504
-49
-1% -$16K 0.31% 72
2024
Q2
$1.42M Sell
4,553
-33
-0.7% -$9.7K 0.32% 69
2024
Q1
$1.3M Sell
4,586
-93
-2% -$27.2K 0.3% 72
2023
Q4
$1.35M Sell
4,679
-84
-2% -$22.9K 0.32% 73
2023
Q3
$1.28M Buy
4,763
+7
+0.1% +$1.75K 0.35% 71
2023
Q2
$1.06M Buy
4,756
+17
+0.4% +$3.94K 0.27% 77
2023
Q1
$1.15M Sell
4,739
-414
-8% -$102K 0.31% 75
2022
Q4
$1.35M Buy
+5,153
New +$1.38M 0.36% 70

Other funds holding AMGN

New Hampshire Trust's AMGN Position: Q2 2026 in Review

New Hampshire Trust increased its Amgen (AMGN) stake by 0.13% in Q2 2026, buying an estimated $1.03K and bringing the position to 2,237 shares worth $810K. The position accounts for 0.15% of the portfolio, ranked #91.

New Hampshire Trust first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.45M in Q3 2024. 1,456 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • New Hampshire Trust held 2,237 shares of Amgen worth $810K as of Q2 2026.
  • New Hampshire Trust bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.15% of New Hampshire Trust's portfolio in Q2 2026, its #91 holding.
  • New Hampshire Trust first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • New Hampshire Trust's Amgen position peaked at $1.45M in Q3 2024.
  • 1,456 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.